These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 28166274)

  • 1. Imputation of adverse drug reactions: Causality assessment in hospitals.
    Varallo FR; Planeta CS; Herdeiro MT; Mastroianni PC
    PLoS One; 2017; 12(2):e0171470. PubMed ID: 28166274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A tailor-made approach for causality assessment for ADR reports on drugs and vaccines.
    Oosterhuis I; Zweers P; Rümke H; Muller-Hansma A; van Puijenbroek EP
    Pharmacoepidemiol Drug Saf; 2019 Apr; 28(4):544-550. PubMed ID: 30168222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interrater agreement of two adverse drug reaction causality assessment methods: A randomised comparison of the Liverpool Adverse Drug Reaction Causality Assessment Tool and the World Health Organization-Uppsala Monitoring Centre system.
    Mouton JP; Mehta U; Rossiter DP; Maartens G; Cohen K
    PLoS One; 2017; 12(2):e0172830. PubMed ID: 28235001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A study of agreement between the Naranjo algorithm and WHO-UMC criteria for causality assessment of adverse drug reactions.
    Belhekar MN; Taur SR; Munshi RP
    Indian J Pharmacol; 2014; 46(1):117-20. PubMed ID: 24550597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of different methods for causality assessment of adverse drug reactions.
    Behera SK; Das S; Xavier AS; Velupula S; Sandhiya S
    Int J Clin Pharm; 2018 Aug; 40(4):903-910. PubMed ID: 30051231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Causality assessment of adverse drug reactions in neonates: a comparative study between Naranjo's algorithm and Du's tool.
    Leopoldino RWD; de Oliveira LVS; Fernandes FEM; de Lima Costa HTM; Vale LMP; Oliveira AG; Martins RR
    Int J Clin Pharm; 2023 Aug; 45(4):1007-1013. PubMed ID: 37212967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A quantitative approach of using genetic algorithm in designing a probability scoring system of an adverse drug reaction assessment system.
    Koh Y; Yap CW; Li SC
    Int J Med Inform; 2008 Jun; 77(6):421-30. PubMed ID: 17921048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of WHO-UMC and Naranjo Scales for Causality Assessment of Reported Adverse Drug Reactions.
    Pandit S; Soni D; Krishnamurthy B; Belhekar MN
    J Patient Saf; 2024 Jun; 20(4):236-239. PubMed ID: 38345209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An assessment of reported adverse drug reactions in a Tertiary Care Hospital in South India: A retrospective cross-sectional study.
    Gupta SK; Kumar KD
    Int J Pharm Investig; 2017; 7(4):193-197. PubMed ID: 29692979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of two methods to assess causality of adverse drug reactions].
    Kyonen M; Folatre I; Lagos X; Vargas S
    Rev Med Chil; 2015 Jul; 143(7):880-6. PubMed ID: 26361025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Causality assessment of adverse drug reactions: comparison of the results obtained from published decisional algorithms and from the evaluations of an expert panel, according to different levels of imputability.
    Macedo AF; Marques FB; Ribeiro CF; Teixeira F
    J Clin Pharm Ther; 2003 Apr; 28(2):137-43. PubMed ID: 12713611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse drug reaction causality assessment tools for drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: room for improvement.
    Goldman JL; Chung WH; Lee BR; Chen CB; Lu CW; Hoetzenecker W; Micheletti R; Yasuda SU; Margolis DJ; Shear NH; Struewing JP; Pirmohamed M
    Eur J Clin Pharmacol; 2019 Aug; 75(8):1135-1141. PubMed ID: 30918988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and inter-rater reliability of the Liverpool adverse drug reaction causality assessment tool.
    Gallagher RM; Kirkham JJ; Mason JR; Bird KA; Williamson PR; Nunn AJ; Turner MA; Smyth RL; Pirmohamed M
    PLoS One; 2011; 6(12):e28096. PubMed ID: 22194808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The utility of the World Health Organization-The Uppsala Monitoring Centre (WHO-UMC) system for the assessment of adverse drug reactions in hospitalized children.
    Tantikul C; Dhana N; Jongjarearnprasert K; Visitsunthorn N; Vichyanond P; Jirapongsananuruk O
    Asian Pac J Allergy Immunol; 2008; 26(2-3):77-82. PubMed ID: 19054924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initial development and testing of an instrument for patient self-assessment of adverse drug reactions.
    Jarernsiripornkul N; Chaipichit N; Pratipanawatr T; Uchaipichat V; Krska J
    Pharmacoepidemiol Drug Saf; 2016 Jan; 25(1):54-63. PubMed ID: 26349635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are the Naranjo criteria reliable and valid for determination of adverse drug reactions in the intensive care unit?
    Kane-Gill SL; Kirisci L; Pathak DS
    Ann Pharmacother; 2005 Nov; 39(11):1823-7. PubMed ID: 16204392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accuracy in patient-reported adverse drug reactions and their recognition: a mixed-methods study.
    Kampichit S; Srisuriyachanchai W; Pratipanawatr T; Jarernsiripornkul N
    Int J Clin Pharm; 2024 Apr; 46(2):401-410. PubMed ID: 38151687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methods for causality assessment of adverse drug reactions: a systematic review.
    Agbabiaka TB; Savović J; Ernst E
    Drug Saf; 2008; 31(1):21-37. PubMed ID: 18095744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Causality assessment of adverse drug reactions by applying a global introspection method in a high complexity hospital.
    Rezende de Menezes R; Graciano Silva MDD; Pinho Ribeiro AL; Martins Pinto Filho M; Martinho GH; Carvalho Ferreira LE; Parreiras Martins MA
    Explor Res Clin Soc Pharm; 2021 Sep; 3():100064. PubMed ID: 35480605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Agreement between WHO-UMC causality scale and the Naranjo algorithm for causality assessment of adverse drug reactions.
    Shukla AK; Jhaj R; Misra S; Ahmed SN; Nanda M; Chaudhary D
    J Family Med Prim Care; 2021 Sep; 10(9):3303-3308. PubMed ID: 34760748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.